Med. praxi. 2010;7(1):19-22

Obesity - diagnostics and treatment in the general practice

MUDr.Radka Braunerová, Ph.D., doc.MUDr.Vojtěch Hainer, CSc.
Centrum pro diagnostiku a léčbu obezity, Endokrinologický ústav, Praha

Obesity has become a serious global health and socioeconomic problem. Prevalence of obesity has been rising steadily in both developed

and developing countries. Obesity increases the risk of a wide range of diseases, especially cardiovascular and metabolic, as well

as oncological diseases, and psychiatric and locomotive disorders. It is associated with increased mortality. To characterize obesity not

only body weight and Body Mass Index are determined but also waist circumference is measured as an indicator of the amount of abdominal

fat. The therapeutic approach includes low energy diet and increased physical activity, which can be supported by medication,

psychological therapy and/or surgery. Recommended medication includes sibutramine or orlistat. Surgical treatment aims to reduce

food intake or/and absorption of macronutrients.

Keywords: obesity, sibutramine, orlistat, bariatric surgery

Published: April 22, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Braunerová R, Hainer V. Obesity - diagnostics and treatment in the general practice. Med. praxi. 2010;7(1):19-22.
Download citation

References

  1. WHO: Obesity: Preventing and managing the global epidemic. Report of a WHO consultation. Geneva, WHO Technical Report Series 894, 2000.
  2. James WPT, Rigby N, Leach R. The obesity epidemic, metabolic syndrome and future prevention strategies. Eur J Cardiovasc Prev Rehabil 2004; 11: 3-8. Go to original source... Go to PubMed...
  3. Tsigos C, Hainer V, Basdevant A, et al. Management of Obesity in Adults: European Clinical Practice Guidelines. Obes Facts 2008; 1: 106-116. Go to original source... Go to PubMed...
  4. Kyle US, Bosaeus I, De Lorenzo AD, et al. Bioelectrical impedance analysis - part II: utilization in clinical practice. Clin. Nutr. 2004; 23: 1430-1453. Go to original source... Go to PubMed...
  5. Knowler WC, Barret-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403. Go to original source... Go to PubMed...
  6. Sacks FM, Bray GA, Carey JV, et al. Comparison of WeightLoss Diets with Different Compositions of Fat, Protein, and Carbohydrates. N Engl J Med. 2009; 360: 859-873. Go to original source... Go to PubMed...
  7. Hainer V, et al. Základy klinické obezitologie. Praha: Grada, 2004: 356.
  8. Fried M, Hainer V, Basdevant A, et al. Inter-disciplinary European guidelines on surgery of severe obesity. Int J Obes (Lond) 2007; 31: 569-577. Go to original source... Go to PubMed...




Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.